Boosted- lopinavir versus boosted- atazanavir plus two nucleoside reverse transcriptase inhibitors in second- line antiretroviral therapy in HIV-1 infected patients in Abidjan (Ivory Coast)

Introduction: Atazanavir is a protease inhibitor recently introduce in the therapeutic arsenal for second-line antiretroviral therapy in Ivory Coast. The objective of this study was to compare the efficacy and safety of a second-line treatment with 2 NRTIs + boosted lopinavir (LPV/r) versus 2 NRTIs...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ehui Eboi, Kassi Indouba Alain, Kouakou Affoue Gisele, Mossou Melaine Chrysostome, Doumbia Adama, Ello Nogbou Frederic, Kamagate Sinaly, Koffi Tanon Aristophane, Eholie Serge Paul
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Eldaghayes Publisher 2016-04-01
Schriftenreihe:	Journal of Microbiology and Infectious Diseases
Schlagworte:	abidjan; atazanavir; hiv; lopinavir; second-line; sub-saharan africa
Online-Zugang:	http://www.ejmanager.com/fulltextpdf.php?mno=302657017
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!